Effect of mutations on the p53 IRES RNA structure Implications for de-regulation of the synthesis of p53 isoforms

被引:37
|
作者
Grover, Richa [1 ]
Sharathchandra, Arandkar [1 ]
Ponnuswamy, Anand [1 ]
Khan, Debjit [1 ]
Das, Saumitra [1 ]
机构
[1] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India
关键词
p53mRNA; regulation of p53 isoforms; IRES RNA secondary structure; IRES trans acting factors; INTERNAL RIBOSOME ENTRY; CELLULAR MESSENGER-RNAS; C-MYC-IRES; TRANSLATION INITIATION; GENE-EXPRESSION; DNA-DAMAGE; 5'-UNTRANSLATED REGION; INHIBITS TRANSLATION; MULTIPLE-MYELOMA; PROTEIN;
D O I
10.4161/rna.8.1.14260
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Earlier we have demonstrated the presence of internal ribosome entry site (IRES) within tumor suppressor p53 mRNA. Here we have mapped the putative secondary structure of p53-IRES RNA using information from chemical probing and nuclease mapping experiments. Additionally, the secondary structure of the IRES element of the wild-type RNA was compared with cancer-derived silent mutant p53 RNAs. These mutations might result in the conformational alterations of p53-IRES RNAs. The results also indicate decreased IRES activities of the mutants as compared to wild-type RNA. Further, it was observed that some of the cytoplasmic trans-acting factors, critical for enhancing IRES function, were unable to bind mutant RNAs as efficiently as to wild-type. Our results suggest that hnRNP C1/C2 binds to p53-IRES and siRNA mediated partial silencing of hnRNP C1/C2 showed appreciable decrease in IRES function and consequent decrease in the level of the corresponding p53 isoform. Interestingly mutant p53 IRES showed lesser binding with hnRNP C1/C2 protein. Finally, upon doxorubicin treatment, the mutant RNAs were unable to show enhanced p53 synthesis to similar extent compared to wild type. Taken together, these observations suggest that mutations occurring in the p53 IRES might have profound implications for de-regulation of its expression and activity.
引用
收藏
页码:132 / 142
页数:11
相关论文
共 50 条
  • [21] p53 and little brother p53/47: linking IRES activities with protein functions
    Grover, R.
    Candeias, M. M.
    Fahraeus, R.
    Das, S.
    ONCOGENE, 2009, 28 (30) : 2766 - 2772
  • [22] p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
    Fujita, Kaori
    Mondal, Abdul M.
    Horikawa, Izumi
    Nguyen, Giang H.
    Kumamoto, Kensuke
    Sohn, Jane J.
    Bowman, Elise D.
    Mathe, A. Mathe
    Schetter, Aaron J.
    Pine, Sharon R.
    Ji, Helen
    Vojtesek, Borivoj
    Bourdon, Jean-Christophe
    Lane, David P.
    Harris, Curtis C.
    CANCER RESEARCH, 2010, 70
  • [23] p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
    Kaori Fujita
    Abdul M. Mondal
    Izumi Horikawa
    Giang H. Nguyen
    Kensuke Kumamoto
    Jane J. Sohn
    Elise D. Bowman
    Ewy A. Mathe
    Aaron J. Schetter
    Sharon R. Pine
    Helen Ji
    Borivoj Vojtesek
    Jean-Christophe Bourdon
    David P. Lane
    Curtis C. Harris
    Nature Cell Biology, 2009, 11 : 1135 - 1142
  • [24] p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
    Fujita, Kaori
    Mondal, Abdul M.
    Horikawa, Izumi
    Nguyen, Giang H.
    Kumamoto, Kensuke
    Sohn, Jane J.
    Bowman, Elise D.
    Mathe, Ewy A.
    Schetter, Aaron J.
    Pine, Sharon R.
    Ji, Helen
    Vojtesek, Borivoj
    Bourdon, Jean-Christophe
    Lane, David P.
    Harris, Curtis C.
    NATURE CELL BIOLOGY, 2009, 11 (09) : 1135 - U208
  • [25] p53 mutations in cancer
    Muller, Patricia A. J.
    Vousden, Karen H.
    NATURE CELL BIOLOGY, 2013, 15 (01) : 2 - 8
  • [26] p53 mutations in chondrosarcoma
    Terek, RM
    Healey, JH
    Garin-Chesa, P
    Mak, S
    Huvos, A
    Albino, AP
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1998, 7 (01) : 51 - 56
  • [27] p53 mutations in cancer
    Patricia A. J. Muller
    Karen H. Vousden
    Nature Cell Biology, 2013, 15 : 2 - 8
  • [28] Are p53 mutations and p53 overexpression prognostic factors for astrocytic tumors?
    Ishii, N
    de Tribolet, N
    CRITICAL REVIEWS IN NEUROSURGERY, 1998, 8 (05) : 269 - 274
  • [29] Mutations in p53, p53 protein overexpression and breast cancer survival
    Rossner, Pavel, Jr.
    Gammon, Marilie D.
    Zhang, Yu-Jing
    Terry, Mary Beth
    Hibshoosh, Hanina
    Memeo, Lorenzo
    Mansukhani, Mahesh
    Long, Chang-Min
    Garbowski, Gail
    Agrawal, Meenakshi
    Kalra, Tara S.
    Gaudet, Mia M.
    Teitelbaum, Susan L.
    Neugut, Alfred I.
    Santella, Regina M.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (9B) : 3847 - 3857
  • [30] Dipeptide analysis of p53 mutations and evolution of p53 family proteins
    Huang, Qiang
    Yu, Long
    Levine, Arnold J.
    Nussinov, Ruth
    Ma, Buyong
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2014, 1844 (01): : 198 - 206